美东时间2020年5月15日,ORIC股价今开33.4600美元,盘中最高34.5000美元,盘中最低31.4100美元,股价收跌3.89%,跌1.3200点,报32.6500美元

ORIC简介

Oric Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. Profound advancements in oncology drug development have expanded the treatment options available to patients, yet therapeutic resistance and relapse continue to limit the efficacy and duration of clinical benefit of such treatments. Collectively, its founders and management team have a decades-long heritage of identifying and characterizing resistance mechanisms in oncology, having discovered and developed groundbreaking medicines at companies such as Ignyta, Medivation, Aragon and Genentech.